Table 3.
Isolated pathogens following patient review (N = 44)
| Isolates | Raw numbers | Percent | |
|---|---|---|---|
| Preoperative | CNS | 3 | 6.8 |
| MRSE | 2 | 4.5 | |
| MSSA | 3 | 6.8 | |
| MRSA | 6 | 13.6 | |
| Propionibacterium acnes | 1 | 2.3 | |
| No isolates | 29 | 65.9 | |
| Intraoperative | CNS | 13 | 29.5 |
| MRSE | 2 | 4.5 | |
| MSSA | 9 | 20.5 | |
| MRSA | 7 | 15.9 | |
| Propionibacterium acnes | 6 | 13.6 | |
| Corynebacterium spp. | 2 | 4.5 | |
| Escherichia coli | 1 | 2.3 | |
| Enterococcus spp. | 2 | 4.5 | |
| Pseudomonas aeruginosa | 3 | 6.8 | |
| Peptostreptococcus magnus | 1 | 2.3 | |
| No isolates | 10 | 22.7 |
CNS coagulase-negative staphylococci, MRSE methicillin-resistant Staphylococcus epidermidis, MSSA methicillin-sensitive S. ureus, MRSA methicillin-resistant S. aureus